Translational Research on Synergy of PD-1 Checkpoint Blockade and Oncolytic Measles Virotherapy

被引：0
|
作者：
Veinalde, Ruta [1 ,2 ]
Pidelaserra-Marti, Gemma [1 ,2 ]
Heidbuechel, Johannes P. W. [1 ,2 ]
Kang, Na [1 ,2 ]
Abate-Daga, Daniel [3 ]
Ball, Claudia R. [4 ,5 ]
Ungerechts, Guy [1 ,2 ]
Engeland, Christine E. [1 ,2 ]
机构：
[1] Natl Ctr Tumor Dis, Heidelberg, Germany
[2] German Canc Res Ctr, Heidelberg, Germany
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] Natl Ctr Tumor Dis, Dresden, Germany
[5] German Canc Res Ctr, Dresden, Germany
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
252
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [1] Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
    Chen, Chun-Yu
    Wang, Pin-Yi
    Hutzen, Brian
    Sprague, Les
    Swain, Hayley M.
    Love, Julia K.
    Stanek, Joseph R.
    Boon, Louis
    Conner, Joe
    Cripe, Timothy P.
    SCIENTIFIC REPORTS, 2017, 7
  • [2] Cooperation of Oncolytic Herpes Virotherapy and PD-1 Blockade in Murine Rhabdomyosarcoma Models
    Chun-Yu Chen
    Pin-Yi Wang
    Brian Hutzen
    Les Sprague
    Hayley M. Swain
    Julia K. Love
    Joseph R. Stanek
    Louis Boon
    Joe Conner
    Timothy P. Cripe
    Scientific Reports, 7
  • [3] Translational research in oncolytic measles virotherapy: early discoveries and future steps
    Msaouel, Pavlos
    Opyrchal, Mateusz
    Galanis, Evanthia
    FUTURE MICROBIOLOGY, 2011, 6 (02) : 125 - 128
  • [4] Immunotherapy: Oncolytic virotherapy enables checkpoint blockade
    Crunkhorn S.
    Nature Reviews Drug Discovery, 2018, 17 (2) : 96 - 96
  • [5] Telomerase-specific oncolytic virotherapy promotes therapeuticefficacy of PD-1 blockade in murine osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2018, 78 (13)
  • [6] Immune checkpoint blockade enhances measles virotherapy
    Engeland, C. E.
    Veinalde, R.
    Grossardt, C.
    Bossow, S.
    Shevchenko, I.
    Umansky, V.
    Nettelbeck, D. M.
    Jaeger, D.
    von Kallel, C.
    Ungerechts, G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 48 - 48
  • [7] Biology of PD-1 Checkpoint Blockade
    Sharpe, Arlene H.
    BLOOD, 2017, 130
  • [8] Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
    Weijie Ma
    Barbara M. Gilligan
    Jianda Yuan
    Tianhong Li
    Journal of Hematology & Oncology, 9
  • [9] Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
    Ma, Weijie
    Gilligan, Barbara M.
    Yuan, Jianda
    Li, Tianhong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [10] Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer
    Sun, Fan
    Guo, Zong Sheng
    Gregory, Alyssa D.
    Shapiro, Steven D.
    Xiao, Gutian
    Qu, Zhaoxia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345